Omicron subvariant XBB.1.5 should be the focus of Covid shots this autumn.

> XBB.1.5 strain of Covid CFOTO | Future Publishing | Getty Images The U.S. Food and Drug Administration (FDA) has released a recommendation for Covid vaccine manufacturers to develop single-strain shots for the fall that specifically target the omicron subvariant XBB.1.5. This strain is currently the dominant variant of the virus nationwide. In their official …

Read more

FDA advisors recommend targeting XBB variant with Covid vaccines this fall.

A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters The U.S. Food and Drug Administration’s independent panel of advisors on Thursday recommended updating Covid shots for the fall and winter to target one specific variant – the …

Read more

The Arduous Road Ahead for Novavax’s Survival

In this illustration photo taken in Krakow, Poland on December 2, 2021, medical syringes and the Novavax logo are prominently displayed in the background. Novavax, a cash-strapped Covid vaccine maker, is confident about its ability to survive and thrive. The Maryland-based company recently announced its first-quarter financial results, which included a cost-cutting initiative and a …

Read more

Alzheimer’s drug gains FDA adviser’s endorsement for complete approval.

An FDA advisory panel has unanimously recommended granting full approval to Leqembi, a new type of Alzheimer’s drug that modestly slows cognitive decline in patients in the early stages of the disease. The panel voted 6-0 in favor of Leqembi, which treats people with early-stage Alzheimer’s and mild cognitive impairment by targeting sticky plaques of …

Read more